GB9806095D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9806095D0
GB9806095D0 GBGB9806095.7A GB9806095A GB9806095D0 GB 9806095 D0 GB9806095 D0 GB 9806095D0 GB 9806095 A GB9806095 A GB 9806095A GB 9806095 D0 GB9806095 D0 GB 9806095D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9806095.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9806095.7A priority Critical patent/GB9806095D0/en
Publication of GB9806095D0 publication Critical patent/GB9806095D0/en
Priority to EP99916852A priority patent/EP1064388A1/en
Priority to AU35192/99A priority patent/AU3519299A/en
Priority to CA002323760A priority patent/CA2323760A1/en
Priority to PCT/EP1999/001894 priority patent/WO1999049055A1/en
Priority to JP2000538015A priority patent/JP2002507425A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
GBGB9806095.7A 1998-03-20 1998-03-20 Novel compounds Ceased GB9806095D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9806095.7A GB9806095D0 (en) 1998-03-20 1998-03-20 Novel compounds
EP99916852A EP1064388A1 (en) 1998-03-20 1999-03-17 Human casb12 polypeptide, a serine protease
AU35192/99A AU3519299A (en) 1998-03-20 1999-03-17 Human casb12 polypeptide, a serine protease
CA002323760A CA2323760A1 (en) 1998-03-20 1999-03-17 Human casb12 polypeptide, a serine protease
PCT/EP1999/001894 WO1999049055A1 (en) 1998-03-20 1999-03-17 Human casb12 polypeptide, a serine protease
JP2000538015A JP2002507425A (en) 1998-03-20 1999-03-17 Human CASB12 polypeptide which is a serine protease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9806095.7A GB9806095D0 (en) 1998-03-20 1998-03-20 Novel compounds

Publications (1)

Publication Number Publication Date
GB9806095D0 true GB9806095D0 (en) 1998-05-20

Family

ID=10829021

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9806095.7A Ceased GB9806095D0 (en) 1998-03-20 1998-03-20 Novel compounds

Country Status (6)

Country Link
EP (1) EP1064388A1 (en)
JP (1) JP2002507425A (en)
AU (1) AU3519299A (en)
CA (1) CA2323760A1 (en)
GB (1) GB9806095D0 (en)
WO (1) WO1999049055A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6921658B1 (en) 1998-11-20 2005-07-26 Fuso Pharmacutical Industries, Ltd. Serine protease BSSP6
CZ20013268A3 (en) * 1999-03-11 2002-02-13 Smithkline Beecham Biologicals S. A. Novel polypeptides and polynucleotides
WO2001072826A2 (en) * 2000-03-24 2001-10-04 Genzyme Corporation Oncogenic osteomalacia-related gene 1
US20040048266A1 (en) * 2000-08-07 2004-03-11 Yonghong Xiao Regulation of human membrane-type serine protease
AU2002213949A1 (en) * 2000-09-25 2002-04-02 Bayer Aktiengesellschaft Regulation of human serine protease
EP2295553A1 (en) * 2002-02-08 2011-03-16 Novozymes A/S Phytase variants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5840871A (en) * 1997-01-29 1998-11-24 Incyte Pharmaceuticals, Inc. Prostate-associated kallikrein
ATE440951T1 (en) * 1997-12-17 2009-09-15 Serono Genetics Inst Sa EXTENDED CDNS CODING SECRETED PROTEINS

Also Published As

Publication number Publication date
CA2323760A1 (en) 1999-09-30
AU3519299A (en) 1999-10-18
JP2002507425A (en) 2002-03-12
WO1999049055A1 (en) 1999-09-30
EP1064388A1 (en) 2001-01-03

Similar Documents

Publication Publication Date Title
GB9801392D0 (en) Novel compounds
GB9803287D0 (en) Novel compounds
GB9802661D0 (en) Novel compounds
GB9800324D0 (en) Novel compounds
GB9800337D0 (en) Novel compounds
GB9801630D0 (en) Novel compounds
GB9801632D0 (en) Novel compounds
GB9801633D0 (en) Novel compounds
GB9801634D0 (en) Novel compounds
GB9801635D0 (en) Novel compounds
GB9801643D0 (en) Novel compounds
GB9801882D0 (en) Novel compounds
GB9802387D0 (en) Novel compounds
GB9802533D0 (en) Novel compounds
GB9802638D0 (en) Novel compounds
GB9802639D0 (en) Novel compounds
GB9802640D0 (en) Novel compounds
GB9802644D0 (en) Novel compounds
GB9802645D0 (en) Novel compounds
GB9803289D0 (en) Novel compounds
GB9802653D0 (en) Novel compounds
GB9802654D0 (en) Novel compounds
GB9802655D0 (en) Novel compounds
GB9802656D0 (en) Novel compounds
GB9802657D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)